An innovative treatment for debilitating and often deadly cases of recurrent C diff infection has been given a Breakthrough Therapy Designation by the FDA. Developed by US biotech firm Rebiotix ...

Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Standard antibiotic treatment clears most infections ... CDI can also result in significant health complications. People with ...

diff to participate in a clinical trial. FMT offers hope to patients suffering from recurrent C. diff infection, as a safe and effective treatment. The majority of patients with recurrent C.

As infectious bacteria go, Clostridium difficile may be one of the most vexing for researchers, clinicians, and patients alike. It spreads from person to person by ingestion of the bacterium’s spores, ...

Clostridium difficile infection is increasingly common with a high risk of recurrence despite antibiotic treatment. In cases of recurrent C. difficile infection, fecal microbiota transplant (FMT ...

Although this treatment is relatively new it has ... NICE have found that the evidence supporting FMT for recurrent Clostridium difficile infection is sufficient for the procedure to be carried ...

FDA approved to prevent recurrent C. difficile infection (rCDI ... Home to help patients with rCDI across the U.S. receive treatment at home as well as health care settings Ferring continues ...